NYSE:CNMDMedical Equipment
CONMED Refocuses On Surgical Growth While Shares Trade Below Estimates
CONMED (NYSE:CNMD) plans to exit its gastroenterology product lines, reallocating resources to surgical and orthopedic platforms.
The move follows strong fourth quarter and full year results, with management highlighting focus areas such as robotic and laparoscopic surgery, smoke evacuation, and orthopedic soft tissue repair.
The announcement comes with the stock around $38.69, after a 44.4% decline over the past year and a 59.9% decline over three years.
For investors tracking NYSE:CNMD,...